NOVO-B:CPH
Novo Nordisk A/S
DKKÂ 259.60
arrow_downward
-1.46%(-3.85) Siku 1
16 Okt, 17:00:00 GMT +2 · DKK
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya NOVO-B...
Fungua
DKKÂ 261.00
Juu
DKKÂ 262.15
Chini
DKKÂ 259.35
Mtaji wa soko
893.13B
Wastani wa kiasi cha mauzo
5.23M
Kiasi cha mauzo ya hisa
5.27M
Juu kwa wiki 52
DKKÂ 409.95
Chini kwa wiki 52
DKKÂ 224.25
Hisa za wawekezaji
3.39B
Idadi ya wafanyakazi
elfu 67
Fungua
DKKÂ 261.00
Juu
DKKÂ 262.15
Chini
DKKÂ 259.35
Mtaji wa soko
893.13B
Wastani wa kiasi cha mauzo
5.23M
Kiasi cha mauzo ya hisa
5.27M
Juu kwa wiki 52
DKKÂ 409.95
Chini kwa wiki 52
DKKÂ 224.25
Hisa za wawekezaji
3.39B
Idadi ya wafanyakazi
elfu 67
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
The Motley Fool
·
saa 9 zilizopita
Novo Nordisk and Eli Lilly Just Got Some Fantastic News
ad-hoc-news.de
·
saa 10 zilizopita
Novo-Nordisk stock: Citi cuts target for Novo-Nordisk stock to DKK 296
Traders Union
·
saa 18 zilizopita
Novo Nordisk shares technical analysis: Buyer support underpins upward price move
Foreign Policy Journal
·
siku 1 iliyopita
Novo Nordisk (NYSE: NVO) Stock Price May Be 63% Undervalued As Buyback And Pipeline Catalysts Mount
Wasifu
Novo Nordisk A/S, doing business as Novo, is a Danish multinational pharmaceutical company. Novo manufactures and markets pharmaceutical products and services, primarily diabetes and obesity medications and devices. The corporation was created in 1989, through a merger of two Danish pharmaceutical companies, which date back to the 1920s.
Novo employs approximately 68,800 people in 80 countries, and markets its products in approximately 170 countries. Novo is controlled by majority shareholder Novo Holdings which holds 28% of its shares and a majority of its voting shares.
Novo is a full member of the European Federation of Pharmaceutical Industries and Associations.
The company was ranked 25th among Fortune's 100 Best Companies to Work For in 2010, and subsequently ranked 72nd in 2014 and 73rd in 2017. In January 2012, Novo was named the most sustainable company in the world by the business magazine Corporate Knights. It is a leader in the FTSE4Good Index, and the only European company in the top ten.
Novo is the largest pharmaceutical company in Denmark. In 2023, Novo's market capitalization exceeded the GDP of Denmark, and it became the highest valued company in Europe. Wikipedia
Kuhusu Novo Nordisk A/S
Afisa Mkuu Mtendaji (CEO)Maziar Mike Doustdar
Wafanyakazielfu 66.7
Lilianzishwa1923
Makao makuuBagsværd, Capital Region of Denmark, Denmaki
Sekta-
Tovutinovonordisk.com